glp 1 triple agonist PDB-101: Molecule of the Month: GLP-1 Receptor Agonists A peptide triple agonist of
Description
Identifying factors that predict a persons response to GLP1 medications may help guide treatment strategy, including choice of drug, dose and speed of dose escalation
Citations M
Stimulation of -cell proliferation secondary to stimulating GLP-1R is usually only observed in young animals (during periods characterized by preserved proliferative capacity), and not in older rodents [548]
Konig et al
The glucagon component adds a dimension of metabolic activation that the other compounds simply do not possess
FDA cleared its Phase 1 Investigational New Drug application on June 23, 2026
